← All trials
NCT06294912
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 18, 2024
- Primary completion
- Mar 24, 2025
- Completion date
- Mar 24, 2025
- First posted
- Mar 6, 2024
- Last posted
- Jun 27, 2024
- Enrollment
- 42
- Arms / groups
- 8 / —
- Source
- AACT · ctgov ingestion
Sponsors
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.